From the ∗Department of Nuclear Medicine, Korea Cancer Centre Hospital, Korea Institute of Radiological and Medical Sciences
†Division of Applied RI, Research Institute of Radiological and Medical Sciences, Korea Institutes of Radiological and Medical Sciences
‡Department of Radiological and Medico-Oncological Sciences, University of Science and Technology
§Division of Hematology/Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.
Conflicts of interest and sources of funding: This project has been funded in part with a grant from the Korea Institute of Radiological and Medical Sciences, funded by the Ministry of Science and ICT, Republic of Korea (no. 50547-2022), and in part with grants from the National Research Foundation of Korea, funded by the Ministry of Science and ICT, Republic of Korea (no. 2020R1A2C2102492). The authors have no conflicts of interest to disclose.
Received for publication May 25, 2022; revision accepted July 17, 2022.
H.J.K and I.L. should be considered joint corresponding authors.
Correspondence to: Hye Jin Kang, MD, PhD, Division of Hematology/Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, 75, Nowon-ro, Nowon-gu, Seoul, South Korea. E-mail: [email protected]; and Ilhan Lim, MD, PhD, Department of Nuclear Medicine, Korea Cancer Centre Hospital, Korea Institute of Radiological and Medical Sciences, 75, Nowon-ro, Nowon-gu, Seoul, South Korea. E-mail: [email protected].
